Hayat Pharmaceutical Industries Co. PLC (ASE: HPIC)

Market Cap	23.75M
Revenue (ttm)	16.42M
Net Income (ttm)	2.95M
Shares Out	9.50M
EPS (ttm)	0.30
PE Ratio	8.35
Forward PE	n/a
Dividend	0.17 (6.60%)
Ex-Dividend Date	n/a

Volume	220
Open	2.550
Previous Close	2.510
Day's Range	2.500 - 2.550
52-Week Range	2.400 - 2.630
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 12, 2025

About ASE: HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 236
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2023, HPIC's revenue was 15.81 million, a decrease of -7.61% compared to the previous year's 17.11 million. Earnings were 2.33 million, a decrease of -34.04%.